|
|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
| |
| Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new
trends and marketing opportunities, as well as highlighting the latest innovations in this
dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.
We're also on Twitter! Follow us @PMPSmag
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Debut Event Showcases Newest Trends in Drug Manufacturing and Delivery
London, UK, 22 September 2022 / Sciad Newswire / Connect in Pharma — the new annual event from Easyfairs — had its debut launch on 14 & 15 September in Geneva. Key players from companies in the pharmaceutical industry, including Bayer, Merck, Pfizer, Roche, Johnson & Johnson and GSK, among other, came together at Palexpo Convention Centre during the two-day event to hear about the latest innovations and developments in pharmaceutical manufacturing, drug delivery and contract manufacturing.
More info >> |
|
 |
White Papers |
 |
|
The Role of the CRO in Effective Risk-Based Monitoring
Medpace
The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >> |
|
|
